We are live on ! Find out more
EM

Excalibur Management Portfolio holdings

AUM $278M
1-Year Est. Return 20.09%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+20.09%
3 Year Est. Return
+68.93%
5 Year Est. Return
+93.63%
10 Year Est. Return
+240.99%
AUM
$153M
AUM Growth
+$41.6M
Cap. Flow
+$30.8M
Cap. Flow %
20.11%
Top 10 Hldgs %
45.73%
Holding
111
New
46
Increased
41
Reduced
16
Closed
1

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.44M
2
AVB icon
AvalonBay Communities
AVB
+$954K
3
INDB icon
Independent Bank
INDB
+$928K
4
MSFT icon
Microsoft
MSFT
+$888K
5
JNJ icon
Johnson & Johnson
JNJ
+$864K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$216K
2
BP icon
BP
BP
+$203K
3
FDX icon
FedEx
FDX
+$148K
4
CSL icon
Carlisle Companies
CSL
+$116K
5
META icon
Meta Platforms (Facebook)
META
+$80.2K

Sector Composition

Rank Sector Weight
1 Healthcare 19.08%
2 Industrials 17.01%
3 Financials 16.36%
4 Technology 13.67%
5 Communication Services 11.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSL icon
1
Carlisle Companies
CSL
$14.1B
$13.4M 8.74%
82,607
-755
-0.9% -$116K
T icon
2
AT&T
T
$169B
$8.36M 5.46%
283,118
+14,731
+5% +$425K
AAPL icon
3
Apple
AAPL
$4.99T
$6.62M 4.33%
90,196
+22,404
+33% +$1.44M
VZ icon
4
Verizon
VZ
$201B
$6.51M 4.25%
105,958
+10,614
+11% +$640K
MSFT icon
5
Microsoft
MSFT
$2.92T
$6.38M 4.17%
40,468
+6,046
+18% +$888K
JNJ icon
6
Johnson & Johnson
JNJ
$643B
$6.21M 4.06%
42,609
+6,372
+18% +$864K
PFE icon
7
Pfizer
PFE
$144B
$6.08M 3.98%
163,672
-697
-0.4% -$24.8K
BRK.B icon
8
Berkshire Hathaway Class B
BRK.B
$1.11T
$6.07M 3.97%
26,781
+1,321
+5% +$287K
MRK icon
9
Merck
MRK
$326B
$5.36M 3.5%
61,711
-19
-0% -$1.56K
JPM icon
10
JPMorgan Chase
JPM
$950B
$5.01M 3.27%
35,925
+2,977
+9% +$382K
PG icon
11
Procter & Gamble
PG
$347B
$4.35M 2.85%
34,849
+4,516
+15% +$553K
CVS icon
12
CVS Health
CVS
$140B
$4.01M 2.62%
53,961
+6,726
+14% +$472K
XOM icon
13
ExxonMobil
XOM
$634B
$3.26M 2.13%
46,778
+3,246
+7% +$224K
CVX icon
14
Chevron
CVX
$374B
$2.73M 1.78%
22,625
+3,672
+19% +$433K
INDB icon
15
Independent Bank
INDB
$4.1B
$2.59M 1.69%
31,065
+11,348
+58% +$928K
PEP icon
16
PepsiCo
PEP
$195B
$2.59M 1.69%
18,923
+1,528
+9% +$208K
INTC icon
17
Intel
INTC
$435B
$2.55M 1.67%
42,675
+12,141
+40% +$679K
V icon
18
Visa
V
$697B
$2.37M 1.55%
12,615
+1,025
+9% +$185K
RTX icon
19
RTX Corp
RTX
$295B
$2.27M 1.49%
24,119
+6,991
+41% +$634K
KO icon
20
Coca-Cola
KO
$380B
$2.13M 1.39%
38,393
+2,502
+7% +$135K
CSCO icon
21
Cisco
CSCO
$456B
$1.83M 1.2%
38,188
+8,758
+30% +$407K
IBM icon
22
IBM
IBM
$214B
$1.77M 1.15%
13,781
+4,348
+46% +$565K
UPS icon
23
United Parcel Service
UPS
$89.7B
$1.68M 1.1%
14,347
-87
-0.6% -$10.3K
AMGN icon
24
Amgen
AMGN
$212B
$1.51M 0.99%
6,255
-15
-0.2% -$3.31K
GIS icon
25
General Mills
GIS
$20.1B
$1.38M 0.9%
25,730
+6,639
+35% +$350K

Similar funds

Excalibur Management's Q4 2019 Portfolio in Review

As of Q4 2019, Excalibur Management held 111 positions worth $153M, up 37% from $111M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Excalibur Management deployed $30.8M of net new capital in Q4 2019, opening 46 new positions and adding to 41 existing holdings. Its largest new stake was AvalonBay Communities: 4,455 shares worth $934K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $216K trimmed.

  • Excalibur Management's largest Q4 2019 buy was AvalonBay Communities: 4,455 shares worth $934K.
  • Excalibur Management added most to Apple in Q4 2019, an estimated $1.44M increase.
  • Excalibur Management's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $216K.
  • Excalibur Management fully exited BP in Q4 2019, selling an estimated $203K.
  • Excalibur Management's ten largest holdings make up 46% of its $153M portfolio in Q4 2019.
  • Excalibur Management opened 46 new positions and closed 1 in Q4 2019.
  • Excalibur Management's portfolio value rose 37% quarter-over-quarter to $153M.

Based on Excalibur Management's 13F filing for Q4 2019, filed 4 Feb 2020.